Skip to main content
. 2016 Mar 23;150(1):102–111. doi: 10.1016/j.chest.2016.03.017

Table 2.

On-Study Management and Clinical Outcomes for Liberal vs Conservative Fluid Management by Baseline Biomarker Concentration

Variable B-Type Natriuretic Peptide
Above Median
P Value Below Median
P Value
Liberal
(n = 146)
Conservative
(n = 167)
Liberal
(n = 163)
Conservative
(n = 150)
On-study management
 Cumulative fluid balance, L 7.0 ± 10.5 1.2 ± 11.0 < .001 6.9 ± 8.9 –0.3 ± 9.0 < .001
 Total furosemide dose, mg 132 ± 228 409 ± 485 < .001 130 ± 232 553 ± 642 < .001
Clinical outcomes
 Death by 60 d, No. (%) 41 (28) 36 (22) .18 32 (20) 27 (18) .71
 Ventilator-free days 12.6 ± 10.4 15.9 ± 10.4 .001 13.9 ± 9.7 15.7 ± 10.1 .04
 Duration of mechanical ventilation, overall, d 14.4 ± 14.8 10.7 ± 12.2 < .001 13.8 ± 12.0 12.3 ± 12.8 .04
 Duration of mechanical ventilation, among survivors, d 14.4 ± 16.2 10.5 ± 12.9 .001 12.9 ± 11.2 11.4 ± 12.7 .02
 ICU-free days 11.2 ± 9.9 14.7 ± 10.0 < .001 12.8 ± 9.2 13.8 ± 9.6 .24
 ICU length of stay, overall, d 16.4 ± 14.4 11.7 ± 10.1 < .001 15.5 ± 13.7 13.8 ± 11.5 .19
 ICU length of stay, among survivors, d 16.2 ± 15.2 11.4 ± 10.2 < .001 14.9 ± 13.7 13.1 ± 11.3 .16
Variable Aldosterone
Above Median
P Value Below Median
P Value
Liberal
(n = 149)
Conservative
(n = 167)
Liberal
(n = 162)
Conservative
(n = 154)
On-study management
 Cumulative fluid balance, L 6.0 ± 8.7 1.1 ± 10.9 < .001 7.9 ± 10.3 –0.3 ± 9.0 < .001
 Total furosemide dose, mg 114 ± 186 487 ± 593 < .001 145 ± 262 463 ± 538 < .001
Clinical outcomes
 Death by 60 d, No. (%) 25 (17) 37 (22) .23 48 (30) 29 (19) .03
 Ventilator-free days 14.3 ± 9.6 14.4 ± 10.6 .47 12.5 ± 10.3 17.1 ± 9.8 < .001
 Duration of mechanical ventilation, overall, d 13.0 ± 10.9 12.5 ± 13.7 .06 15.0 ± 15.2 10.3 ± 11.0 < .001
 Duration of mechanical ventilation, among survivors, d 12.9 ± 11.2 12.3 ± 14.1 .04 14.1 ± 15.83 9.5 ± 11.2 < .001
 ICU-free days 12.9 ± 9.1 13.0 ± 10.1 .51 11.2 ± 9.9 19.5 ± 9.5 < .001
 ICU length of stay, overall, d 14.4 ± 11.0 13.7 ± 12.2 .12 17.3 ± 16.2 11.6 ± 9.4 < .001
 ICU length of stay, among survivors, d 14.3 ± 10.6 13.5 ± 12.3 .08 16.7 ± 17.4 10.8 ± 8.7 .002

Data are given as mean ± SD or as otherwise indicated.